Jul 29 |
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
|
Jul 2 |
Stifel starts Rapport at buy, cites lead drug candidate RAP-219
|
Jun 29 |
No Holiday Break For Tesla, Constellation Brands, Comcast, And Trump Media
|
Jun 12 |
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
|
Jun 7 |
Rapport Therapeutics starts trading above IPO price
|
Jun 7 |
J&J-backed Rapport Therapeutics prices IPO at $17 per share
|
Jun 6 |
Rapport Therapeutics Announces Pricing of Initial Public Offering
|
Jun 3 |
J&J-backed Rapport Therapeutics sets terms for $136M IPO
|